Financial Report
1 January - 31 December
|
kEUR |
Note |
2022 |
2021 |
|
|
|
|
|
|
Revenue |
3 |
280,978 |
282,126 |
|
Other operating income |
3 |
2,486 |
4,091 |
|
Total income |
|
283,464 |
286,217 |
|
|
|
|
|
|
Cost of sales |
|
-228,987 |
-182,426 |
|
Gross profit |
|
54,477 |
103,791 |
|
|
|
|
|
|
Marketing and sales expenses |
3 |
-4,905 |
-3,864 |
|
Research expenses |
3 |
-1,243 |
-1,407 |
|
General and administrative expenses |
3 |
-35,722 |
-34,355 |
|
Total operating expenses |
|
-41,870 |
-39,626 |
|
|
|
|
|
|
Operating result (EBIT) |
|
12,607 |
64,165 |
|
|
|
|
|
|
Financial income |
3 |
9 |
653 |
|
Financial expenses |
3 |
-5,049 |
-4,970 |
|
Total financial result |
|
-5,040 |
-4,317 |
|
|
|
|
|
|
Result before income taxes |
|
7,567 |
59,848 |
|
|
|
|
|
|
Income tax charges |
5 |
200 |
-12,590 |
|
Result for the year |
|
7,767 |
47,258 |
|
|
|
|
|
|
Attributable to shareholders of PolyPeptide Group AG |
|
7,767 |
47,258 |
|
|
|
|
|
|
Earnings per share in EUR, basic |
7 |
0.24 |
1.47 |
|
Earnings per share in EUR, diluted |
7 |
0.24 |
1.47 |